
1. hematology soc hematol educ program. 2005:368-72.

cryoglobulinemia.

morra e(1).

author information: 
(1)niguarda ca' granda hospital, piazza ospedale maggiore 3, milano 20162, italy.
ematologia@ospedaleniguarda.it

mixed cryoglobulinemia (mc) type ii disorder characterized circulating
cold-precipitable immune complexes composed polyclonal immunoglobulin igg 
monoclonal igm rheumatoid factor (rf). systemic vasculitis which
characterizes disease caused deposition immune complexes 
walls small vessels, subsequent activation complement
cascade. mc may asymptomatic lead clinical manifestations characterized 
by typical triad--purpura, arthralgia, weakness--and cases a
more serious vasculitis neurologic renal involvement. vast
majority (more 90%) patients, mc associated hepatitis c virus
(hcv) infection, considered triggering factor disease. the
association cryoglobulinemia hcv infection, possible
evolution b-cell lymphomas usually long-term follow-up, suggest role
of hcv infection pathogenesis mc lymphomagenesis. fact, 
the virus chronically stimulates polyclonal proliferation b cells from
which monoclonal population may emerge. paper also reviews treatment
strategies mc syndrome, emphasizing issue eradication hcv, 
the clinical biological activity rituximab selective b-cell control.

doi: 10.1182/asheducation-2005.1.368 
pmid: 16304405  [indexed medline]

